MARKET

TECH

TECH

Bio-Techne Corp
NASDAQ
81.79
-1.39
-1.67%
Closed 17:00 05/31 EDT
OPEN
82.58
PREV CLOSE
83.18
HIGH
82.67
LOW
79.51
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
99.34
52 WEEK LOW
67.80
MARKET CAP
12.88B
P/E (TTM)
48.93
1D
5D
1M
3M
1Y
5Y
Bio-Techne Corp: Specialized disclosure report
Press release · 11h ago
This Favorable Sign Appears On Bio-Techne's Chart
Benzinga · 17h ago
BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
PR Newswire · 6d ago
Bio-Techne Corporation: Long-Term Quality, But At A Price
Seeking Alpha · 05/18 22:42
EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
PR Newswire · 05/18 11:00
Bio-Techne Says Interim Study Results Show Prostate Cancer Risk Test is More Accurate Than Standard of Care
Bio-Techne Says Interim Study Results Show Prostate Cancer Risk Test is More Accurate Than Standard of Care
MT Newswires · 05/18 09:07
SVB Securities Sticks to Their Buy Rating for Bio-Techne (TECH)
TipRanks · 05/17 00:36
BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
PR Newswire · 05/16 11:00
More
About TECH
Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.

Webull offers kinds of BIO-TECHNE Corp stock information, including NASDAQ:TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TECH stock methods without spending real money on the virtual paper trading platform.